Mar 21, 2026Do GLP-1 Drugs Raise Cancer Risk? What Trials ShowDo Ozempic, Wegovy, and Mounjaro raise cancer risk? Evidence from 48 trials and 94,245 patients finds no signal within 2–5 years.liraglutideglp-1 agoniststhyroid cancerRead article →
Feb 28, 2026SELECT’s Undercovered Result: Fewer Hospitalizations on SemaglutideSELECT made headlines for fewer heart attacks and strokes. The quieter result: semaglutide also cut hospital admissions and hospital days in high-risk obesity.semaglutideglp-1 agonistweight lossRead article →